Anticoagulants Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 19-Jan-2022
No. of pages: 68

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

This report contains market size and forecasts of Anticoagulants in Global, including the following market information:

Global Anticoagulants Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anticoagulants market was valued at 26700 million in 2021 and is projected to reach US$ 36330 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Platelet Aggregation Inhibitors (PAI) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulants companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anticoagulants Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anticoagulants Market Segment Percentages, by Type, 2021 (%)

- Platelet Aggregation Inhibitors (PAI)

- Low-Molecular-Weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Direct Factor Xa Inhibitors (DFXa)

- Vitamin K antagonists (VKA)

- Others

Global Anticoagulants Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anticoagulants Market Segment Percentages, by Application, 2021 (%)

- VTE

- ACS/MI

- AF

- Others

Global Anticoagulants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anticoagulants Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anticoagulants revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anticoagulants revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Sanofi

- Bristol-Myers Squibb

- Bayer

- Johnson & Johnson.

- Genentech (Roche)

- Boehringer Ingelheim

- Lilly

- Daiichi Sankyo

- Otsuka

- AstraZeneca

- Pfizer

- Aspen

- The Medicines Company

Anticoagulants Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anticoagulants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticoagulants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticoagulants Overall Market Size
2.1 Global Anticoagulants Market Size: 2021 VS 2028
2.2 Global Anticoagulants Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticoagulants Players in Global Market
3.2 Top Global Anticoagulants Companies Ranked by Revenue
3.3 Global Anticoagulants Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulants Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anticoagulants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulants Players in Global Market
3.6.1 List of Global Tier 1 Anticoagulants Companies
3.6.2 List of Global Tier 2 and Tier 3 Anticoagulants Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anticoagulants Market Size Markets, 2021 & 2028
4.1.2 Platelet Aggregation Inhibitors (PAI)
4.1.3 Low-Molecular-Weight Heparin (LMWH)
4.1.4 Direct Thrombin Inhibitor (DTI)
4.1.5 Direct Factor Xa Inhibitors (DFXa)
4.1.6 Vitamin K antagonists (VKA)
4.1.7 Others
4.2 By Type - Global Anticoagulants Revenue & Forecasts
4.2.1 By Type - Global Anticoagulants Revenue, 2017-2022
4.2.2 By Type - Global Anticoagulants Revenue, 2023-2028
4.2.3 By Type - Global Anticoagulants Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anticoagulants Market Size, 2021 & 2028
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - Global Anticoagulants Revenue & Forecasts
5.2.1 By Application - Global Anticoagulants Revenue, 2017-2022
5.2.2 By Application - Global Anticoagulants Revenue, 2023-2028
5.2.3 By Application - Global Anticoagulants Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anticoagulants Market Size, 2021 & 2028
6.2 By Region - Global Anticoagulants Revenue & Forecasts
6.2.1 By Region - Global Anticoagulants Revenue, 2017-2022
6.2.2 By Region - Global Anticoagulants Revenue, 2023-2028
6.2.3 By Region - Global Anticoagulants Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anticoagulants Revenue, 2017-2028
6.3.2 US Anticoagulants Market Size, 2017-2028
6.3.3 Canada Anticoagulants Market Size, 2017-2028
6.3.4 Mexico Anticoagulants Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anticoagulants Revenue, 2017-2028
6.4.2 Germany Anticoagulants Market Size, 2017-2028
6.4.3 France Anticoagulants Market Size, 2017-2028
6.4.4 U.K. Anticoagulants Market Size, 2017-2028
6.4.5 Italy Anticoagulants Market Size, 2017-2028
6.4.6 Russia Anticoagulants Market Size, 2017-2028
6.4.7 Nordic Countries Anticoagulants Market Size, 2017-2028
6.4.8 Benelux Anticoagulants Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anticoagulants Revenue, 2017-2028
6.5.2 China Anticoagulants Market Size, 2017-2028
6.5.3 Japan Anticoagulants Market Size, 2017-2028
6.5.4 South Korea Anticoagulants Market Size, 2017-2028
6.5.5 Southeast Asia Anticoagulants Market Size, 2017-2028
6.5.6 India Anticoagulants Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anticoagulants Revenue, 2017-2028
6.6.2 Brazil Anticoagulants Market Size, 2017-2028
6.6.3 Argentina Anticoagulants Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anticoagulants Revenue, 2017-2028
6.7.2 Turkey Anticoagulants Market Size, 2017-2028
6.7.3 Israel Anticoagulants Market Size, 2017-2028
6.7.4 Saudi Arabia Anticoagulants Market Size, 2017-2028
6.7.5 UAE Anticoagulants Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Anticoagulants Major Product Offerings
7.1.4 Sanofi Anticoagulants Revenue in Global Market (2017-2022)
7.1.5 Sanofi Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Anticoagulants Major Product Offerings
7.2.4 Bristol-Myers Squibb Anticoagulants Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anticoagulants Major Product Offerings
7.3.4 Bayer Anticoagulants Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Johnson & Johnson.
7.4.1 Johnson & Johnson. Corporate Summary
7.4.2 Johnson & Johnson. Business Overview
7.4.3 Johnson & Johnson. Anticoagulants Major Product Offerings
7.4.4 Johnson & Johnson. Anticoagulants Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson. Key News
7.5 Genentech (Roche)
7.5.1 Genentech (Roche) Corporate Summary
7.5.2 Genentech (Roche) Business Overview
7.5.3 Genentech (Roche) Anticoagulants Major Product Offerings
7.5.4 Genentech (Roche) Anticoagulants Revenue in Global Market (2017-2022)
7.5.5 Genentech (Roche) Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Anticoagulants Major Product Offerings
7.6.4 Boehringer Ingelheim Anticoagulants Revenue in Global Market (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Lilly
7.7.1 Lilly Corporate Summary
7.7.2 Lilly Business Overview
7.7.3 Lilly Anticoagulants Major Product Offerings
7.7.4 Lilly Anticoagulants Revenue in Global Market (2017-2022)
7.7.5 Lilly Key News
7.8 Daiichi Sankyo
7.8.1 Daiichi Sankyo Corporate Summary
7.8.2 Daiichi Sankyo Business Overview
7.8.3 Daiichi Sankyo Anticoagulants Major Product Offerings
7.8.4 Daiichi Sankyo Anticoagulants Revenue in Global Market (2017-2022)
7.8.5 Daiichi Sankyo Key News
7.9 Otsuka
7.9.1 Otsuka Corporate Summary
7.9.2 Otsuka Business Overview
7.9.3 Otsuka Anticoagulants Major Product Offerings
7.9.4 Otsuka Anticoagulants Revenue in Global Market (2017-2022)
7.9.5 Otsuka Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Anticoagulants Major Product Offerings
7.10.4 AstraZeneca Anticoagulants Revenue in Global Market (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Anticoagulants Major Product Offerings
7.11.4 Pfizer Anticoagulants Revenue in Global Market (2017-2022)
7.11.5 Pfizer Key News
7.12 Aspen
7.12.1 Aspen Corporate Summary
7.12.2 Aspen Business Overview
7.12.3 Aspen Anticoagulants Major Product Offerings
7.12.4 Aspen Anticoagulants Revenue in Global Market (2017-2022)
7.12.5 Aspen Key News
7.13 The Medicines Company
7.13.1 The Medicines Company Corporate Summary
7.13.2 The Medicines Company Business Overview
7.13.3 The Medicines Company Anticoagulants Major Product Offerings
7.13.4 The Medicines Company Anticoagulants Revenue in Global Market (2017-2022)
7.13.5 The Medicines Company Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anticoagulants Market Opportunities & Trends in Global Market
Table 2. Anticoagulants Market Drivers in Global Market
Table 3. Anticoagulants Market Restraints in Global Market
Table 4. Key Players of Anticoagulants in Global Market
Table 5. Top Anticoagulants Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anticoagulants Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anticoagulants Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anticoagulants Product Type
Table 9. List of Global Tier 1 Anticoagulants Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticoagulants Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Anticoagulants Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anticoagulants Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anticoagulants Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Anticoagulants Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anticoagulants Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anticoagulants Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Anticoagulants Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anticoagulants Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anticoagulants Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anticoagulants Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anticoagulants Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anticoagulants Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anticoagulants Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anticoagulants Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anticoagulants Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anticoagulants Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anticoagulants Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anticoagulants Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anticoagulants Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Anticoagulants Product Offerings
Table 32. Sanofi Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Anticoagulants Product Offerings
Table 35. Bristol-Myers Squibb Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Anticoagulants Product Offerings
Table 38. Bayer Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson. Corporate Summary
Table 40. Johnson & Johnson. Anticoagulants Product Offerings
Table 41. Johnson & Johnson. Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 42. Genentech (Roche) Corporate Summary
Table 43. Genentech (Roche) Anticoagulants Product Offerings
Table 44. Genentech (Roche) Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Anticoagulants Product Offerings
Table 47. Boehringer Ingelheim Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 48. Lilly Corporate Summary
Table 49. Lilly Anticoagulants Product Offerings
Table 50. Lilly Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 51. Daiichi Sankyo Corporate Summary
Table 52. Daiichi Sankyo Anticoagulants Product Offerings
Table 53. Daiichi Sankyo Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 54. Otsuka Corporate Summary
Table 55. Otsuka Anticoagulants Product Offerings
Table 56. Otsuka Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Anticoagulants Product Offerings
Table 59. AstraZeneca Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Anticoagulants Product Offerings
Table 62. Pfizer Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 63. Aspen Corporate Summary
Table 64. Aspen Anticoagulants Product Offerings
Table 65. Aspen Anticoagulants Revenue (US$, Mn), (2017-2022)
Table 66. The Medicines Company Corporate Summary
Table 67. The Medicines Company Anticoagulants Product Offerings
Table 68. The Medicines Company Anticoagulants Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anticoagulants Segment by Type in 2021
Figure 2. Anticoagulants Segment by Application in 2021
Figure 3. Global Anticoagulants Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anticoagulants Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anticoagulants Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticoagulants Revenue in 2021
Figure 8. By Type - Global Anticoagulants Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anticoagulants Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anticoagulants Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anticoagulants Revenue Market Share, 2017-2028
Figure 12. US Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anticoagulants Revenue Market Share, 2017-2028
Figure 16. Germany Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 17. France Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anticoagulants Revenue Market Share, 2017-2028
Figure 24. China Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 28. India Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anticoagulants Revenue Market Share, 2017-2028
Figure 30. Brazil Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anticoagulants Revenue Market Share, 2017-2028
Figure 33. Turkey Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anticoagulants Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson. Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genentech (Roche) Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lilly Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Daiichi Sankyo Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Otsuka Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AstraZeneca Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pfizer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Aspen Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. The Medicines Company Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs